VMD Investor Presentation updateViemed has updated the April 2021 Investor Presentation
https://www.viemed.com/wp-content/uploads/2021/04/VMD-Deck-April-2021.pdf
A summary of changes since the February 2021 Presentation
Figures from the February 2021 presentation
Currently serving over 21,000 patients
Reports 2019 Annual revenues of $US 80.3 Million
Total Staff 515
Cash on Hand $US 32.4 Million as of Sept 30, 2020
Long term debt $US 7.2 Million as of Sept 30, 2020
Oustanding shares issued 39,107,640
Outstanding shares fully diluted (41,155,668)
Market Cap (Dec 31, 2020) $US 335 Million
Stock Price (Dec 31, 2020) $US 8.39
Appendix shows financial figures from 2013-2020Q3
Figures from the April 2021 presentation
Currently serving over 27,000 patients (+28.6% since Feb presentation)
Reports 2020 Annual revenues $US 131.3 Million (+63.5% since prior year)
Total Staff 529 (+2.7% since Feb presentation)
Cash on Hand $US 31 Million as of Mar 31, 2021 (-4.3% since Sept 30, 2020)
Long term debt $US 6.6 Million as of Mar 31, 2021 (-8.3% since Sept 30, 2020)
Outstanding shares 38,743,516 (-0.0093% since prior presentation)
Outstanding shares fully diluted (40,525,737) (-0.0153% since prior presentation)
Market Cap (Mar 31, 2021) $US 405 Million (+20.9% since last quarter)
Stock Price (Mar 31, 2021) $US 10.12 (+20.6% since last quarter)
Appendix shows financial figures from 2017-2020 (2013-2016 deleted from the table)